Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gatifloxacin in Bacterial Conjunctivitis
NCT00509873Phase 3Completed
- Sponsor
- Allergan
- Start
- Aug 2007
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of gatifloxacin in bacterial conjunctivitis (BC), sponsored by Allergan. Started Aug 2007; status: completed.
02
Drugs
gatifloxacin
03
Conditions
bacterial conjunctivitis (BC)
Beyond the preview
Go deeper on NCT00509873.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00509873.